Wells Fargo & Company Tonix Pharmaceuticals Holding Corp. Transaction History

Wells Fargo & Company

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.46 - $1.3 $13 - $37	29 Added 7.4%	421 $0
Q4 2022 Feb 13, 2023	BUY	$0.29 - $0.57 $30 - $60	106 Added 37.06%	392 $0
Q3 2022 Nov 14, 2022	BUY	$0.53 - $1.9 $85 - $305	161 Added 128.8%	286 $0
Q2 2022 Aug 12, 2022	BUY	$1.58 - $7.36 $197 - $920	125 New	125 $0

Ticker TNXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,752,700
Market Cap $7.25M
Description
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.